Team

Dr. Anczukow is an independent investigator who studies the role and regulation of alternative RNA in cancer pathogenesis.  She completed her Ph.D. at University Claude Bernard Lyon 1 in France, and her postdoctoral training at Cold Spring Harbor laboratory, NY, USA. She is an Affiliated Faculty at the UConn Health Department of Genetics and Genome Sciences, and an Investigator at the UConn Institute for System Genomics, and an Affiliated Faculty at the Yale Center for RNA Science and Medicine.

Her innovative integrative research approach seamlessly connects RNA biology, cancer research, and aging. She has made significant mechanistic discoveries that pave the way for new personalized cancer therapies. Notably, she identified novel oncogenic splicing alterations that play a crucial role in tumor initiation and metastasis. Additionally, her work has elucidated transcriptional and post-transcriptional pathways that regulate splicing defects in cancer. Her research has also contributed to the development of cutting-edge long-read sequencing platforms and RNA-based strategies to correct splicing defects.

She is the recipient of prestigious awards such as the RNA society Scaringe Award, the NIH/NCI Career Development Award, and the V Scholar Award. She has co-organized international conferences, including the FASEB RNA Processing in Cancer Conference: From Bench to Bedside (2023), Forbeck Forum on Therapeutic targeting of RNA Splicing (2023), and The Long-Read Sequencing Workshop (2024). She is a member of the RNA Society and the American Association for Cancer Research, and serves on the AACR Aging and Stress Advisory Task Force. She also served on several study sections and peer review groups.

Finally, Dr. Anczukow is dynamically engaged in the research community, in the training of the next generation of cancer researchers by mentoring junior faculty, postdocs and students, and in science outreach programs.